Abstract
Although gene therapy and immunotherapy hold great promise for the future, cancer treatment now centers around surgical resection, radiation therapy, and chemotherapy. The therapeutic basis of surgical resection is obvious, but the same cannot be said for the other approaches. What accounts for the selective killing of malignant cells while normal cells are spared? It is clearly not simple differences in rates of replication. Why do cancers even of the same histologic type vary in their sensitivity to chemotherapy and radiotherapy? What accounts for the frustrating development of drug resistance? Recent findings provide a possible link between these questions and . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
